April 22, 2024

Startup Lounge #121: The Merall Bioproducts Story

The MCEI Start-up Lounge – Your place for inspiration and networking in Mannheim’s start-up ecosystem.

This Time with bioRN as Host!

The MCEI Startup Lounge is your place to get inspired to create something new and to meet and mingle with the Mannheim Startup Ecosystem. Meet startups and creative minds to discuss great ideas in a laid-back atmosphere. Every Startup Lounge features an inspirational talk by a (usually early-stage) venture to get the discussion going and has some budget to cover drinks (provided by either MCEI or one of our co-feature partners). Join us if you are into startups and want to expand your network in the Rhine-Neckar Metropolitan Region and live the entrepreneurial spirit.

At Merall Bioproducts, we are rethinking what aquaculture can be, not just a source of protein, but a launchpad for sustainable materials. Our Mission is to produce healthy meat with a novel aquaculture system and converting waste into sustainable biomaterials.

Workflow Optimisation in the Laboratory: Premiere of the smartLabs Summit in Heidelberg

On September 24, 2025, the smartLabs Summit will open its doors for the first time in Heidelberg – an event dedicated to practical innovation, digitalization, and automation in laboratories. The Summit will take place at BioLabs Heidelberg (Nicola-Tesla Straße 1–3, 69124 Heidelberg) and offers a full program from 1:00 to 7:30 p.m. Initiated by the […]

DFG awards Heidelberg research project on early detection of spinal degeneration nearly €250,000 in funding

The aim of the project is to use special quantitative MRI to visualize early changes in the intervertebral disc and enable timely treatment. Ultrashort echo time (UTE) MRI opens up completely new approaches to preventive imaging that are difficult or impossible to achieve with conventional MRI methods. Full text in German below. DFG fördert Heidelberger […]

Glioblastoma study shows: Molecular diagnostics could enable targeted therapies without delay

Researchers from Heidelberg University’s Medical Faculty, the German Cancer Research Center (DKFZ), and the National Center for Tumor Diseases (NCT) in Heidelberg have tested the use of targeted drugs in the initial treatment of newly diagnosed glioblastoma, an extremely aggressive brain tumor, in the multicenter study “NCT Neuro Master Match (N2M2)”. Of the five drugs […]

Startup Lounge #121: The Merall Bioproducts Story

Our latest News

Workflow Optimisation in the Laboratory: Premiere of the smartLabs Summit in Heidelberg

DFG awards Heidelberg research project on early detection of spinal degeneration nearly €250,000 in funding

Glioblastoma study shows: Molecular diagnostics could enable targeted therapies without delay

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!